Laboratory of Immunoregulation

Laboratory of Immunoregulation
Name	Laboratory of Immunoregulation
Established	1980s
Location	City Research Campus
Director	Dr. Jane Doe
Staff	120
Focus	Immunology, inflammation, tolerance
Affiliation	Institute for Biomedical Sciences

Laboratory of Immunoregulation

The Laboratory of Immunoregulation is a biomedical research unit specializing in immune system control, host-pathogen interactions, and translational immunotherapy. The laboratory operates within a major research campus and engages with academic, clinical, and industrial partners to advance therapies and diagnostics. It contributes to basic science and clinical translation through multidisciplinary teams and cross-institutional consortia.

Overview

The laboratory was founded amid advances from groups such as Peter Medawar, Frank Macfarlane Burnet, Niels K. Jerne, Jules Bordet, and Paul Ehrlich and draws intellectual lineage from institutions like National Institutes of Health, Wellcome Trust, Max Planck Society, Cold Spring Harbor Laboratory, and Francis Crick Institute. Leadership has included investigators trained at Harvard University, Stanford University, University of Cambridge, University of Oxford, and Massachusetts Institute of Technology. The unit participates in programs connected to European Molecular Biology Laboratory, Howard Hughes Medical Institute, Howard Hughes Medical Institute Janelia Research Campus, NIH Clinical Center, and European Research Council grants. Funders and partners have included Bill & Melinda Gates Foundation, National Science Foundation, Wellcome Trust Sanger Institute, and Chan Zuckerberg Initiative.

Research Focus and Projects

Active projects address immune tolerance influenced by pathways first characterized by Charles Janeway, Ruslan Medzhitov, Ralph Steinman, and Bruce Beutler; studies of antigen presentation reference work from Rolf Zinkernagel, Zbyszek Skowronski, and Emil von Behring. Projects include modulation of checkpoint pathways pioneered by James P. Allison and Tasuku Honjo, vaccine adjuvant design influenced by Adrian Hill and Sarah Gilbert, and cell therapy development following techniques from Carl June and Michel Sadelain. Translational efforts align with clinical trials at centers such as Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, Cleveland Clinic, and UCSF Medical Center.

Methods and Techniques

The laboratory deploys techniques developed in collaborations with groups from Broad Institute, Salk Institute, Karolinska Institutet, EMBL-EBI, and Dana-Farber Cancer Institute. Methods include flow cytometry innovations from Leonard Herzenberg, single-cell transcriptomics informed by work at Single Cell Genomics Consortium, CRISPR screens following protocols from Feng Zhang, Jennifer Doudna, and Emmanuelle Charpentier, and advanced imaging derived from Eric Betzig, Stefan Hell, and William E. Moerner. Proteomics workflows reference advances from Ruedi Aebersold and Albert Heck; computational immunology uses algorithms developed at European Bioinformatics Institute, Carnegie Mellon University, and University of California, Berkeley.

Collaborations and Partnerships

Institutional collaborations include formal partnerships with Imperial College London, University of Toronto, Peking University, Tsinghua University, Seoul National University, National University of Singapore, and Monash University. Clinical research networks include ties to Global Alliance for Vaccines and Immunization, Coalition for Epidemic Preparedness Innovations, International AIDS Vaccine Initiative, Stop TB Partnership, and World Health Organization. Industry partnerships involve biotechnology companies modeled after Genentech, Amgen, Regeneron Pharmaceuticals, Moderna, and BioNTech, and spinouts engage venture partners like Sequoia Capital and NEA.

Facilities and Resources

Core facilities resemble infrastructure at Broad Institute, Scripps Research, Argonne National Laboratory, and Lawrence Berkeley National Laboratory and include BSL-2 and BSL-3 suites analogous to those at Rocky Mountain Laboratories and USAMRIID. Imaging cores host instruments similar to those at Allen Institute for Brain Science. Biobanks follow standards from UK Biobank and All of Us Research Program. High-performance computing resources interface with XSEDE and cloud platforms like Amazon Web Services and Google Cloud Platform for large-scale sequence analysis.

Training and Education Programs

Training programs mirror curricula from Cold Spring Harbor Laboratory Courses, EMBO Workshops, Gordon Research Conferences, and postgraduate schemes at Wellcome Trust PhD Programmes. The laboratory runs internships modeled on NIH Postdoctoral Training Program and exchanges with Ludwig Institute for Cancer Research, St. Jude Children’s Research Hospital, and Fred Hutchinson Cancer Research Center. Professional development involves collaborations with American Association of Immunologists, European Federation of Immunological Societies, and International Union of Immunological Societies.

Notable Findings and Impact

Contributions build on seminal discoveries linked to Janeway's immunological theory, Steinman's dendritic cell research, and checkpoint blockade advances by Allison and Honjo. Outcomes include preclinical models of tolerance informed by work from Shimon Sakaguchi and Timothy Springer, identification of biomarkers akin to signatures described by Atul Butte and Eric Schadt, and vaccine constructs comparable to those from Katalin Karikó and Derrick Rossi. The laboratory’s translational pipeline has influenced protocols used at FDA, European Medicines Agency, NIH Clinical Center, and contributed data to consortia such as Human Cell Atlas and COVID-19 Genomics UK Consortium.

Category:Immunology laboratories